Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD)
Sponsor: Universidad San Francisco de Quito
Summary
The goal of this clinical trial is to determine the effects of Saccharomyces boulardii (Sb) consumption on Ecuadorian children with a diagnosis of autism spectrum disorder (ASD) and digestive symptoms. Saccharomyces boulardii is a probiotic, in other words, a beneficial microorganism. The main question it aims to answer is: Does Sb improve intestinal health, defenses against infections, nutrition and behavior of the participants. Researchers will compare children when they are taking and not taking Saccharomyces boulardii to know if there are changes in digestive symptoms, immune system function, nutritional status and behavior. Participants will take Saccharomyces boulardii for 4 months and will be 4 months without taking Sb. All participants must provide stool, urine and blood samples. A medical, nutritional and psychological team will follow the participants at least 5 times during the study.
Official title: Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD) in the Metropolitan District of Quito, Ecuador
Key Details
Gender
All
Age Range
5 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2024-01-06
Completion Date
2026-08
Last Updated
2026-01-15
Healthy Volunteers
No
Conditions
Interventions
S. boulardii CNCM (National Collection of Cultures of Microorganisms) I-745
250 mg three times a day for 4 months
Locations (1)
Neurodesarrollo Quito
Quito, Pichincha, Ecuador